Exosomes were shown to transfer PDGFRβ to melanoma cells, activating the phosphatidylinositol-3-kinase (PI3K-AKT) signaling pathway, involved in the growth and survival of cancer cells, consequently lowering the sensitivity to BRAF inhibitors [65]. The gene discussed is BRAF; the disease is melanoma.